A Waters Kraus Paul & Siegel team led by partner Charles Siegel obtained an important federal court ruling, rejecting an attempt by Carnival Cruise Line to move a worker’s mesothelioma lawsuit to arbitration and ordering the dispute to return to a Texas state court.
Chief U.S. District Judge Cecilia M. Altonaga remanded the case to Texas state court after finding that the family...
National Institutes of Health (NIH) researchers have learned that many mesothelioma patients younger than 40 may experience the disease differently than their older counterparts. Mesothelioma is usually diagnosed in older men who were exposed to asbestos in the workplace. For these patients, mesothelioma traditionally follows a familiar, tragic course.
Mesothelioma Patients Under 40 Look...Malignant pleural mesothelioma may soon be getting a new standard of care. Bevacizumab may be added to the current standard chemotherapy regimen of pemetrexed and cisplatin. According to Dr. Gerald Zalcman, who recently presented a paper at the 2015 American Society of Clinical Oncology (ASCO) annual meeting, bevacizumab offers patients with malignant pleural mesothelioma longer survival rates...
That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus Paul & Siegel has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.
3141 Hood Street, Suite 700
Dallas, Texas 75219
Contact Us 800.226.9880
